James Graham Brown Cancer Center
44
4
6
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
38.6%
17 terminated/withdrawn out of 44 trials
52.8%
-33.7% vs industry average
2%
1 trials in Phase 3/4
68%
13 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (44)
Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer
Role: collaborator
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
Role: collaborator
A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
Role: collaborator
Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer
Role: collaborator
Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer
Role: collaborator
Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers
Role: collaborator
Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Role: collaborator
Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
Role: collaborator
Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer
Role: collaborator
Metabolomic Analysis of Lung Cancer
Role: collaborator
A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients
Role: collaborator
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
Role: collaborator
Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
Role: collaborator
Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox
Role: collaborator
Port Will be Flushed Every 3 Months Instead of Every 4-6 Wks, as Recommended by Port Manufacturer.
Role: collaborator
A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer
Role: collaborator
A Micro/Nano Device for Exhaled Breath Analysis
Role: collaborator
Prognostic Markers of Gynecologic Cancers
Role: collaborator
Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
Role: collaborator
Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
Role: collaborator